About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 102819, 11 pages
http://dx.doi.org/10.1155/2013/102819
Review Article

Somatostatin Receptor-Based Molecular Imaging and Therapy for Neuroendocrine Tumors

1Department of Nuclear Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China
2Department of Nuclear Medicine, Wenzhou Medical University, Wenzhou, Zhejiang 325003, China
3Zhejiang University Medical PET Center, Zhejiang University, Hangzhou, Zhejiang 310009, China
4Institute of Nuclear Medicine and Molecular Imaging, Zhejiang University, Hangzhou, Zhejiang 310009, China
5Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Hangzhou, Zhejiang 310009, China
6Department of Radiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China

Received 17 July 2013; Accepted 8 August 2013

Academic Editor: Mei Tian

Copyright © 2013 Ling Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Ling Wang, Kun Tang, Qi Zhang, et al., “Somatostatin Receptor-Based Molecular Imaging and Therapy for Neuroendocrine Tumors,” BioMed Research International, vol. 2013, Article ID 102819, 11 pages, 2013. doi:10.1155/2013/102819